On July 30, 2026, Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a top CNS precision neuroscience biopharmaceutical company, disclosed its plans to release financial results for the second quarter concluding on June 30, 2026. The report, accompanied by a corporate update, is scheduled for Thursday, August 6, 2026, before markets open.